Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Professor
Frédéric Sacher was trained in electrophysiology in Bordeaux. During his fellowship in Boston at Brigham and Women’s Hospital (Harvard Medical School) with W.G. Stevenson, he was trained to ventricular tachycardia ablation. In 2007, he came back to Bordeaux with a praticien hospitalier position in Michel Haissaguerre’s department. Since 2017, he has a professor position. Dr Sacher routinely… View more
Author(s): Jean-Paul Albenque , Arnaud Chaumeil , Stephane Combes , et al Added: 3 years ago
In the setting of persistent atrial fibrillation (AF), the current ablation strategy combines pulmonary vein (PV) isolation and substrate modulation. Substrate modulation can be performed either by linear lesion deployment or by complex fractionated atrial electrogram (CFE) elimination. These two substrate modulation methods can be either exclusive or complementary. However, although the… View more
Author(s): Maria Min-Young Kim Added: 2 years ago
In this interview, Dr Maria Min-Young Kim (Imperial College Healthcare NHS Trust, London, UK) discusses the results of the GANGLIA-AF Trial, a study that aimed to determine the role of ectopy-triggering ganglionated plexus ablation (ET-GP) in the treatment of Atrial Fibrillation. Questions: 1. Please summarise the main aims, study design and endpoints of this trial? 2. What were your key… View more
Author(s): Matthew Wright Added: 3 years ago
Since the initial description that in the majority of patients paroxysmal atrial fibrillation (AF) is triggered by pulmonary vein (PV) ectopy,1 catheter ablation of AF has gone from a niche procedure to a common one, with approximately 20,000 ablations performed per year in the US alone. However, AF ablation remains a technically difficult procedure, requires long training to become proficient,2… View more
Author(s): Maria Cristina Tavera , Sara Foresti , Riccardo Cappato Added: 3 years ago
Before the advent of surgery only 20% of children with congenital heart disease survived to adult life.1 Great achievements in paediatric cardiology and cardiac surgery over the last few decades resulted in an increased survival of children with congenital heart disease (CHD). Today we are facing the first generation of grown-up congenital heart disease (GUCH) patients and the management of their… View more
Job title: Executive Medical Director
Personal History Dr Natale is an American cardiologist and electrophysiologist known for his work in atrial fibrillation ablation. He was born in Syracuse, Italy and has been practising medicine in the United States and Italy for over 35 years.2 His father, a physician, was a strong influence in his decision to choose cardiology.3 He is known as the first electrophysiologist in the US to… View more
Author(s): Todd Rudo Added: 3 years ago
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice, with a prevalence that substantially increases with age. Both the loss of atrial mechanical function and a rapid, irregular ventricular response contribute to potentially significant symptoms, including palpitations, fatigue, chest discomfort, light headedness or syncope. Additionally, AF is associated with a… View more
Research Area(s) / Expertise: Job title: Director
Dr Claudio Tondo is the Chairman of the Heart Rhythm centre at Centro Cardiologico, University of Milan, Italy. Dr Tondo's interests range from clinical aspects of arrhythmias to genetics. View more
Author(s): Paolo Della Bella Added: 2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis. Discussion Points: Rationale behind this trial … View more
Author(s): Jose L Merino Added: 2 years ago
In this late-breaking interview filmed at EHRA 2022, Dr José Merino(Hospital Universitario La Paz, Madrid, Spain) discusses the findings of the POWER-FAST III trial, a study that aimed to compare atrial fibrillation ablation strategies of conventional radiofrequency ablation and high power radiofrequency ablation. Results suggest that PVA was achieved in both cohorts, with no significant… View more